These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunogenicity and safety of a combined measles, mumps, rubella and varicella live vaccine (ProQuad ®) administered concomitantly with a booster dose of a hexavalent vaccine in 12-23-month-old infants. Deichmann KA; Ferrera G; Tran C; Thomas S; Eymin C; Baudin M Vaccine; 2015 May; 33(20):2379-86. PubMed ID: 25765966 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and safety of a combined hepatitis A and B vaccine administered concomitantly with either a measles-mumps-rubella or a diphtheria-tetanus-acellular pertussis-inactivated poliomyelitis vaccine mixed with a Haemophilus influenzae type b conjugate vaccine in infants aged 12-18 months. Usonis V; Meriste S; Bakasenas V; Lutsar I; Collard F; Stoffel M; Tornieporth N Vaccine; 2005 Apr; 23(20):2602-6. PubMed ID: 15780442 [TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines. Shinefield H; Black S; Thear M; Coury D; Reisinger K; Rothstein E; Xu J; Hartzel J; Evans B; Digilio L; Schödel F; Brown ML; Kuter B; Pediatr Infect Dis J; 2006 Apr; 25(4):287-92. PubMed ID: 16567978 [TBL] [Abstract][Full Text] [Related]
5. Antibody persistence and booster vaccination of a fully liquid hexavalent vaccine coadministered with measles/mumps/rubella and varicella vaccines at 15-18 months of age in healthy South African infants. Madhi SA; Koen A; Cutland C; Groome M; Santos-Lima E Pediatr Infect Dis J; 2013 Aug; 32(8):889-97. PubMed ID: 23538523 [TBL] [Abstract][Full Text] [Related]
6. Does measles-mumps-rubella (MMR) vaccination cause inflammatory bowel disease and autism? Strauss B; Bigham M Can Commun Dis Rep; 2001 Apr; 27(8):65-72. PubMed ID: 11338656 [No Abstract] [Full Text] [Related]
7. Reactogenicity and immunogenicity of combined Haemophilus influenzae type b-meningococcal serogroup C conjugate vaccine booster dose coadministered with measles, mumps, and rubella vaccine. Carmona A; Miranda M; Barrio F; De Vicente A; Mares J; Muñoz E; Diez-Delgado J; Alonso A; Giménez-Sánchez F; Merino J; García-Corbeira P; Maechler G; Boutriau D; Pediatr Infect Dis J; 2010 Mar; 29(3):269-71. PubMed ID: 19952860 [TBL] [Abstract][Full Text] [Related]
8. Simultaneous vaccination of Chinese applicants for a United States immigrant visa. Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068 [TBL] [Abstract][Full Text] [Related]
9. Vaccination history and risk of childhood leukaemia. Ma X; Does MB; Metayer C; Russo C; Wong A; Buffler PA Int J Epidemiol; 2005 Oct; 34(5):1100-9. PubMed ID: 15951359 [TBL] [Abstract][Full Text] [Related]
10. [Vaccination, inflammatory bowel disease and autism--is there a connection?]. Nøkleby H Tidsskr Nor Laegeforen; 2001 Sep; 121(23):2679. PubMed ID: 11699370 [No Abstract] [Full Text] [Related]
11. Macrophagic myofasciitis in children is a localized reaction to vaccination. Lach B; Cupler EJ J Child Neurol; 2008 Jun; 23(6):614-9. PubMed ID: 18281624 [TBL] [Abstract][Full Text] [Related]
12. Vaccination and autoimmune diseases: the argument against. Rubinstein E Isr Med Assoc J; 2004 Jul; 6(7):433-5. PubMed ID: 15274538 [No Abstract] [Full Text] [Related]
13. Has the measles-mumps-rubella vaccine been fully exonerated? Katz SL Pediatrics; 2006 Oct; 118(4):1744-5. PubMed ID: 17015569 [No Abstract] [Full Text] [Related]
14. Measles-mumps-rubella immunisation, autism and inflammatory bowel disease: update. Amin J; Wong M Commun Dis Intell; 1999 Aug; 23(8):222. PubMed ID: 10497836 [No Abstract] [Full Text] [Related]
15. Autism and MMR vaccination in North London; no causal relationship. Taylor B; Lingam R; Simmons A; Stowe J; Miller E; Andrews N Mol Psychiatry; 2002; 7 Suppl 2():S7-8. PubMed ID: 12142932 [No Abstract] [Full Text] [Related]
16. No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Peltola H; Patja A; Leinikki P; Valle M; Davidkin I; Paunio M Lancet; 1998 May; 351(9112):1327-8. PubMed ID: 9643797 [No Abstract] [Full Text] [Related]
17. Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines. Paulke-Korinek M; Fischmeister G; Grac A; Rendi-Wagner P; Kundi M; Mohsenzadeh-Rabbani A; Moritz K; Fenninger B; Jarisch R; Jasinska J; Holzmann H; Wiedermann U; Kollaritsch H Vaccine; 2011 Jul; 29(32):5130-6. PubMed ID: 21624412 [TBL] [Abstract][Full Text] [Related]
18. The MMR vaccination and autism: a lay person's contribution. Hamilton M West Indian Med J; 2001 Mar; 50(1):87-9. PubMed ID: 11398299 [No Abstract] [Full Text] [Related]
19. Immunogenicity and safety of measles-mumps-rubella, varicella and Haemophilus influenzae type b vaccines administered concurrently with a fourth dose of heptavalent pneumococcal conjugate vaccine compared with the vaccines administered without heptavalent pneumococcal conjugate vaccine. Black SB; Cimino CO; Hansen J; Lewis E; Ray P; Corsaro B; Graepel J; Laufer D Pediatr Infect Dis J; 2006 Apr; 25(4):306-11. PubMed ID: 16567981 [TBL] [Abstract][Full Text] [Related]
20. MMR and IBD: the only thing we have to fear is...fear itself. Kugathasan S Inflamm Bowel Dis; 2001 Nov; 7(4):349-50. PubMed ID: 11720330 [No Abstract] [Full Text] [Related] [Next] [New Search]